Fundraising FoxSofinnova Ventures — 2026 Investments
6 investments dated 2026 · listed companies and verified rows first · show all
BiomX builds a portfolio of defense and security companies through subsidiaries, partnerships, and acquisitions, focusing on detection systems, aerial technologies, and infrastructure security.
AI & Machine LearningBiotechCybersecurityDeep TechDefense TechHardwareNess Ziona
Jonathan Solomon(Chief Executive Officer)inMerav Bassan(Chief Development Officer)inMarina Wolfson(Chief Financial Officer)inJesse Goodman(Director)Alan Moses(Director)Jonathan Leff(Director)
Board seatJonathan Leff· per SEC Form D · $3.3M raise · filed Jan 2026
Co-investorsAMR Action FundBaruch Future VenturesNSG VenturesOrbiMedSBI JI Innovation Advisory Ltd.Seventure Partners+2 more
Quanta is a biotech company developing orally bioavailable, CNS-penetrant small-molecule KRAS inhibitors targeting RAS-driven cancers such as pancreatic, colorectal, lung, and endometrial cancers.
BiotechDeep TechHealthtechSouth San Francisco, US
Cameron Pitt(Executive Officer, Director)inDerek Metzger(Executive Officer)
BoardPerry Nisen(Executive Officer, Director)inMaria Fardis(Director)inRajul Jain(Director)in
Board seatMaha Katabi· per SEC Form D
Co-investorsFinchley Healthcare VenturesLongitude CapitalVida VenturesBiotechnology Value FundFrazier Life Sciences
Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment.
BiotechHardwareHealthtechMedical DevicesSan Mateo, US
Dr. Chou(Founder & Chief Executive Officer)Cindy Lynch(Executive Officer)inDr. Joey English(Chief Medical Officer)Tony Chou(Founder)in
BoardJack Lasersohn(Director)inTamir Meiri(Director)
Board seatNoel Jee· per SEC Form D · $50M raise · filed Apr 2026
Co-investorsNovo HoldingsThe Vertical GroupNorwest Venture PartnersRunway Growth CapitalUS Venture PartnersSectoral Asset Management+1 more
Apollo is a venture capital firm that invests in life-science and biotechnology startups, combining entrepreneurial expertise with deep scientific knowledge to support early-stage companies in drug development and personalized medicine.
BiotechDeep TechHealthtechLongevity
Nils Regge(Co-Founder & General Partner)in
Co-investorsBellevue Investments & CoBLN CapitalCoastCapFelix JahnFJ LabsKfW Capital+6 more
Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.
AI & Machine LearningBiotech
Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)inMarie De Vulder(Chief Legal Officer Co-founder)inGuy Peeters(Chief Financial Officer Co-founder)inJohn-Paul Gallivan(Head of Development Co-founder)inFabrice Kolb(Head of Immunology Co-founder)inPieter Peeters(Operating & Technology Officer Co-founder)in
Co-investorsFinchley Healthcare VenturesLongwood FundLuma GroupBAM ElevateForbionNovo Holdings+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.